PBM

Propel Bio Management Portfolio holdings

AUM $82.4M
1-Year Est. Return 29.33%
This Quarter Est. Return
1 Year Est. Return
+29.33%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$121M
AUM Growth
–
Cap. Flow
Cap. Flow %
Top 10 Hldgs %
Holding
34
New
Increased
Reduced
Closed

Top Buys

1
+$21.9M
2
+$18M
3
+$12.2M
4
MDGL icon
Madrigal Pharmaceuticals
MDGL
+$6.95M
5
CRNX icon
Crinetics Pharmaceuticals
CRNX
+$5.87M

Top Sells

No sells this quarter

Sector Composition

1 Healthcare 62.69%
2 Energy 18.15%
3 Technology 2.51%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
1
$21.9M 18.15%
+1,372,360
2
$18M 14.93%
+5,374,982
3
$12.2M 10.09%
+2,087,139
4
$6.95M 5.76%
+30,032
5
$5.87M 4.87%
+165,000
6
$5.06M 4.2%
+750,000
7
$4.05M 3.35%
+443,047
8
$3.95M 3.28%
+270,664
9
$3.68M 3.05%
+594,174
10
$3.63M 3.01%
+1,492,792
11
$3.03M 2.51%
+290,781
12
$2.95M 2.45%
+120,221
13
$2.34M 1.94%
+100,052
14
$2.13M 1.77%
+27,712
15
$2.13M 1.76%
+85,442
16
$2.11M 1.75%
+22,400
17
$2.07M 1.71%
+70,000
18
$1.96M 1.62%
+180,100
19
$1.87M 1.55%
+130,000
20
$1.62M 1.34%
+178,500
21
$1.43M 1.19%
+56,359
22
$1.36M 1.13%
+45,695
23
$1.29M 1.07%
+147,033
24
$986K 0.82%
+146,381
25
$837K 0.69%
+195,000
1
2